Bladder Cancer

Exams and Tests

To determine whether bladder cancer may be the cause of your urinary symptoms, your health professional will evaluate your:

  • Physical symptoms. A physical exam may include a rectal exam, a prostate exam for men, or a pelvic exam for women.
  • Medical history, including your smoking history and your possible exposure to cancer-causing chemicals.
  • Family history of cancer.
  • A urine test and urine culture, to determine the presence of blood, infection, and other abnormal cells.

Initial diagnostic tests will include a cystoscopy, a test that allows your doctor to look at your bladder with a thin lighted scope (cytoscope). Small tissue samples (biopsies) of any abnormal areas are taken and looked at under a microscope to determine whether cancer cells are present and what the cells look like (grade). Information from the biopsy, cytoscopy, and sometimes other tests is used to determine the size and extent of the cancer (stage). Cancer stage and grade tell the size and shape of cancer cells and whether they have spread to other body areas. Knowing the stage and grade helps you and your doctor make treatment decisions.

Other diagnostic tests that may be done include:

If bladder cancer is diagnosed, more tests may be needed to determine whether the cancer has spread (metastasized).

  • A CT scan or MRI may be done to determine whether the cancer has spread to lymph nodes, the lungs, the liver, or other abdominal organs.
  • A chest X-ray may be done to determine whether the cancer has spread to the lungs.
  • A barium enema or colonoscopy may be done to determine whether the cancer involves the intestines.
  • A bone scan may be done to determine whether the cancer has spread to the bones.

Early detection of returning cancer

After you have been treated for bladder cancer, it is important to have regular examinations and cystoscopies to detect any recurrence early so that additional treatment can begin immediately. Researchers are studying ways to identify low-grade cancer cells without the need for a cystoscopy. Some tests for specific proteins in cancer cells (tumor markers), such as BTA and NMP22, have been approved by the U.S. Food and Drug Administration (FDA) to use to detect recurrent cancer.8 More research is being done on these screening methods because they are not as accurate as a cystoscopy at this time.9


Go to previous sectionGo to previous sectionGo to top of pageGo to top of pageGo to next sectionGo to next section

Author: Shannon Erstad, MBA/MPHLast Updated: May 25, 2007
Medical Review: E. Gregory Thompson, MD - Internal Medicine
Philip Belitsky, MD, FRCSC - Urology

© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.

Click here to learn about Healthwise
Click here to learn about Healthwise
Topic Contents
 Topic Overview
 Health Tools Click here to view Health Tools.
 Cause
 Symptoms
 What Happens
 What Increases Your Risk
 When To Call a Doctor
Arrow PointerExams and Tests
 Treatment Overview
 Prevention
 Home Treatment
 Medications
 Surgery
 Other Treatment
 Other Places To Get Help
 Related Information
 References
 Credits